Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Eleonora M. Lad, Robert P. Finger, Robyn Guymer
Format:	Article
Sprog:	English
Udgivet:	Adis, Springer Healthcare 2023-09-01
Serier:	Ophthalmology and Therapy
Fag:	Age-related macular degeneration Biomarkers iAMD Geographic atrophy Neovascular AMD
Online adgang:	https://doi.org/10.1007/s40123-023-00807-9

Lignende værker

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
af: Treefa Shwani, et al.
Udgivet: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
af: İmren Akkoyun
Udgivet: (2014-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
af: Reem H. ElSheikh, et al.
Udgivet: (2022-11-01)

Serum lipids in adults with late age-related macular degeneration: a case-control study
af: Richard D. Semba, et al.
Udgivet: (2019-01-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
af: João Estarreja, et al.
Udgivet: (2024-07-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
af: Julia Nguyen, et al.
Udgivet: (2024-02-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
af: Kiruthika M, et al.
Udgivet: (2025-02-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
af: Răzvan Vasile ROPCIUC
Udgivet: (2024-05-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
af: Sonali Nashine
Udgivet: (2021-09-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
af: Niloofar Piri, et al.
Udgivet: (2023-05-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
af: Anat Loewenstein, et al.
Udgivet: (2024-12-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
af: Grace A. Borchert, et al.
Udgivet: (2023-08-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
af: M. M. Bikbov, et al.
Udgivet: (2022-03-01)

Genetic Insights into Age-Related Macular Degeneration
af: Bhumika, et al.
Udgivet: (2024-07-01)

Early and intermediate age-related macular degeneration: update and clinical review
af: García-Layana A, et al.
Udgivet: (2017-10-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
af: Ines Lains, MD, PhD, et al.
Udgivet: (2024-01-01)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
af: Nicola Ferrante, et al.
Udgivet: (2022-04-01)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
af: Sabrina L. Mitchell, et al.
Udgivet: (2021-11-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
af: Yujong Yi, et al.
Udgivet: (2024-03-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
af: Avaylon J, et al.
Udgivet: (2020-05-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
af: Elżbieta Nowak, et al.
Udgivet: (2018-07-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
af: Audrey Yan, et al.
Udgivet: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
af: Mayank Choubey, et al.
Udgivet: (2023-11-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
af: Ashwin Gupta, et al.
Udgivet: (2022-01-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
af: Rita Flores, et al.
Udgivet: (2021-12-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
af: Sanjay Kumar Mishra, et al.
Udgivet: (2022-07-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
af: Ngoc Thien Le, et al.
Udgivet: (2023-12-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
af: Shashikant Sharma, et al.
Udgivet: (2021-03-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
af: Saurav Mallik, et al.
Udgivet: (2022-06-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
af: Uday Pratap Singh Parmar, et al.
Udgivet: (2025-01-01)

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
af: Mateusz Winiarczyk, et al.
Udgivet: (2024-05-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
af: Xiang Li, et al.
Udgivet: (2024-12-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
af: Deepali R Damkondwar, et al.
Udgivet: (2022-01-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
af: Yingbin Fu, et al.
Udgivet: (2024-02-01)

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
af: Ramandeep Singh, et al.
Udgivet: (2022-01-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
af: Zofia Ulańczyk, et al.
Udgivet: (2020-10-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
af: S. V. Yanchenko, et al.
Udgivet: (2023-01-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
af: Enoch T. Peng, et al.
Udgivet: (2023-05-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
af: Karanvir Gill, et al.
Udgivet: (2024-07-01)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
af: Pongsachareonnont P, et al.
Udgivet: (2018-09-01)